...
LIFC CELEBRATES WORLD CYSTIC FIBROSIS DAY (SEPTEMBER 8) WITH HISTORIC ACHIEVEMENT

September 08, 2025
MAP Communication
MAP Communication

LIFC CELEBRATES WORLD CYSTIC FIBROSIS DAY (SEPTEMBER 8) WITH HISTORIC ACHIEVEMENT

Joint request submitted by LIFC and CFE for inclusion of Kaftrio/Trikafta in the WHO list of essential drugs accepted

On the occasion of World Cystic Fibrosis Day, the Italian Cystic Fibrosis League is celebrating a historic achievement: the request submitted jointly by LIFC and CFE for the inclusion of Kaftrio/Trikafta in the World Health Organization (WHO) list of essential drugs has been accepted.
An important milestone for all patients and in particular a concrete step for those who, even today, do not have access to potentially curative treatments.
Serrata was the awareness campaign conducted by LIFC over the past few months, in order to request the extension of the indication of the drug Kaftrio for all patients aged 2 years and older, with at least one non-class I CFTR mutation.

«We obtained this right because the WHO finally accepted the request presented by LIFC requesting the inclusion of the drug in the list of essential medicines for cystic fibrosis patients, thus providing hope for a cure even in countries where there is difficulty obtaining the drug – commented with pride LIFC President Antonio Guarini –. Our commitment as a national LIFC goes beyond Italy’s borders: every day we work and commit to ensuring care and rights for people with cystic fibrosis wherever they are. This milestone represents concrete hope for thousands of patients and families around the world and demonstrates, once again, how together we can change the future of cystic fibrosis, because we go fast alone but together we go far».

Of great importance, in this context, was the resonance of the events conducted by the Italian Cystic Fibrosis League at a national level, in support of “orphans in care”: last but not least, the project “125 Miles for a Breath” which saw the protagonist the athlete and LIFC sports spokesperson Alessandro Gattafoni engaged in a sea crossing by kayak, from Civitanova Marche to the city of Sebenico, for 180 kilometers.
An incredible challenge for an athlete like Alessandro, strong but still a cystic fibrosis patient. Behind this performance, however, for Alessandro the mission was even deeper: to continue his journey of raising awareness about the disease.

«Initiatives like the one led by Alessandro are essential to shed light on this widespread, yet still too little-known, pathology and to transmit strength to the more than 6,000 Italian patients with cystic fibrosis, as well as to all those facing this challenge, transforming it into a lever for looking to the future with confidence» concluded Guarini.